Patents by Inventor Chunli Huang

Chunli Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230257122
    Abstract: An aircraft seat backrest with a lifesaving function, including a backrest body and a back plate assembly, wherein a containing cavity is arranged in a front face of the backrest body, the back plate assembly includes a back plate covering the containing cavity and a lifesaving parachute pack that is arranged on a back face of the back plate and contained in the containing cavity, the back plate is fixedly connected with the backrest body through a quick release mechanism in a quickly separable manner, lifesaving straps of the lifesaving parachute pack pass through strap through holes in the back plate, and an occupant leans against the back plate and is connected with the back plate and the lifesaving parachute pack through the lifesaving straps when riding.
    Type: Application
    Filed: September 30, 2020
    Publication date: August 17, 2023
    Applicant: AEROSPACE LIFE-SUPPORT INDUSTRIES LTD
    Inventors: Liangliang LI, Bin XIONG, Xi CHENG, Fanhui MENG, Zhaojiang WU, Chunli HUANG
  • Patent number: 7750158
    Abstract: Compounds of Formula I: and/or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions containing such compounds exhibit anti-inflammatory and immunomodulatory activity, and can be effective in treating cancer and inflammatory, immunomodulatory or respiratory diseases or conditions.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: July 6, 2010
    Assignee: Schering Corporation
    Inventors: Bandarpalle B. Shankar, Eric Gilbert, Razia K. Rizvi, Chunli Huang, Joseph A. Kozlowski, Stuart McCombie, Neng-Yang Shih
  • Publication number: 20070178452
    Abstract: Disclosed is a method in which DNA sequences derived from microsome-associated mRNA sequences in a mixed sample or in an arrayed single sequence clone can be determined and classified without sequencing. The methods make use of information on the presence of carefully chosen target subsequences, typically of length from 4 to 8 base pairs, and preferably the length between target subsequences in a sample DNA sequence together with DNA sequence databases containing lists of sequences likely to be present in the sample to determine a sample sequence. The preferred method uses restriction endonucleases to recognize target subsequences and cut the sample sequence. Then carefully chosen recognition moieties are ligated to the cut fragments, the fragments amplified, and the experimental observation made. Polymerase chain reaction (PCR) is the preferred method of amplification.
    Type: Application
    Filed: October 21, 2002
    Publication date: August 2, 2007
    Inventors: Pascal Bouffard, John Herrmann, Chunli Huang, Michael Jeffers, Jingfang Ju, Luca Rastelli, Juliette Shimkets, Jan Simons, Bruce Taillon
  • Publication number: 20060100228
    Abstract: Compounds of Formula I: and/or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions containing such compounds exhibit anti-inflammatory and immunomodulatory activity, and can be effective in treating cancer and inflammatory, immunomodulatory or respiratory diseases or conditions.
    Type: Application
    Filed: June 21, 2005
    Publication date: May 11, 2006
    Inventors: Bandarpalle Shankar, Eric Gilbert, Razia Rizvi, Chunli Huang, Joseph Kozlowski, Stuart McCombie, Neng-Yang Shih
  • Publication number: 20030176385
    Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase. Methods of using these compounds for modulation of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase.expression and for treatment of diseases associated with expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, 1L-8, ion transport, Map3KS and Thymidine kinase are provided.
    Type: Application
    Filed: November 27, 2002
    Publication date: September 18, 2003
    Inventors: Jingfang Ju, Chunli Huang, Haihong Zhong, Jan Fredrik Simons, Bruce E. Taillon, John S. Chant, John A. Peyman, Glennda Smithson, Isabelle Millet